Matches in SemOpenAlex for { <https://semopenalex.org/work/W2601697433> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2601697433 abstract "6626^ Background: Ruxolitinib has demonstrated rapid and durable reductions in splenomegaly and improved disease-related symptoms and QoL in 2 phase 3 studies (COMFORT-I and -II) in pts with primary MF (PMF), post-polycythemia vera-MF (PPV-MF), or post-essential thrombocythemia-MF (PET-MF). The prevalence of individual symptoms among these pts has not been defined. We evaluated the baseline HRQoL and symptoms among pts enrolled in COMFORT-II. Methods: COMFORT-II is a randomized, open-label, multicenter, phase 3 study comparing ruxolitinib with best available therapy. HRQoL and symptoms were assessed at baseline using the European Organisation for the Research and Treatment of Cancer QoL Questionnaire–Core 30 (EORTC QLQ‑C30) and Functional Assessment of Cancer Therapy–Lymphoma (FACT‑Lym); this analysis summarizes these scores for all pts, regardless of assigned treatment. Results: In COMFORT-II (N = 219), 52% of pts were aged > 65 years and 57% were male. By IPSS criteria (Cervantes et al. 2009), 40% had intermediate-2 and 60% had high-risk MF. Mean (95% CI) EORTC global health status/QoL (53.7 [50.6-56.7]; median, 50.0) and FACT-General total scores (73.0 [70.8-75.2]) were comparable to those for pts of similar age with other cancers (Oliva et al. 2011: median global health status score of 50 for acute myeloid leukemia [AML]). The most frequent symptoms (reported as “quite a bit” or “very much”) were fatigue (54%), dyspnea (30%), insomnia (30%), pain (29%), night sweats (23%), and itching (21%), and there were differences in baseline symptoms across MF subtypes (Table). Conclusions: This analysis shows that pts with MF experience severe disease-related symptoms and have diminished HRQoL similar to pts with AML, but because pts with MF have a longer life expectancy (an average of 2.3 to 4 years for high and intermediate-2 risk pts, respectively), they may suffer with a reduced QoL for many years. [Table: see text]" @default.
- W2601697433 created "2017-04-07" @default.
- W2601697433 creator A5001595006 @default.
- W2601697433 creator A5008609620 @default.
- W2601697433 creator A5009381933 @default.
- W2601697433 creator A5013552023 @default.
- W2601697433 creator A5018111458 @default.
- W2601697433 creator A5032370825 @default.
- W2601697433 creator A5042734609 @default.
- W2601697433 creator A5046482086 @default.
- W2601697433 creator A5046772202 @default.
- W2601697433 creator A5046827092 @default.
- W2601697433 creator A5049331182 @default.
- W2601697433 creator A5058952186 @default.
- W2601697433 creator A5069072959 @default.
- W2601697433 creator A5089433535 @default.
- W2601697433 creator A5091547978 @default.
- W2601697433 date "2012-05-20" @default.
- W2601697433 modified "2023-10-08" @default.
- W2601697433 title "Health-related quality of life (HRQoL) and symptom burden in patients (Pts) with myelofibrosis (MF) in the COMFORT-II study." @default.
- W2601697433 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.6626" @default.
- W2601697433 hasPublicationYear "2012" @default.
- W2601697433 type Work @default.
- W2601697433 sameAs 2601697433 @default.
- W2601697433 citedByCount "7" @default.
- W2601697433 countsByYear W26016974332012 @default.
- W2601697433 countsByYear W26016974332013 @default.
- W2601697433 countsByYear W26016974332014 @default.
- W2601697433 countsByYear W26016974332015 @default.
- W2601697433 countsByYear W26016974332016 @default.
- W2601697433 crossrefType "journal-article" @default.
- W2601697433 hasAuthorship W2601697433A5001595006 @default.
- W2601697433 hasAuthorship W2601697433A5008609620 @default.
- W2601697433 hasAuthorship W2601697433A5009381933 @default.
- W2601697433 hasAuthorship W2601697433A5013552023 @default.
- W2601697433 hasAuthorship W2601697433A5018111458 @default.
- W2601697433 hasAuthorship W2601697433A5032370825 @default.
- W2601697433 hasAuthorship W2601697433A5042734609 @default.
- W2601697433 hasAuthorship W2601697433A5046482086 @default.
- W2601697433 hasAuthorship W2601697433A5046772202 @default.
- W2601697433 hasAuthorship W2601697433A5046827092 @default.
- W2601697433 hasAuthorship W2601697433A5049331182 @default.
- W2601697433 hasAuthorship W2601697433A5058952186 @default.
- W2601697433 hasAuthorship W2601697433A5069072959 @default.
- W2601697433 hasAuthorship W2601697433A5089433535 @default.
- W2601697433 hasAuthorship W2601697433A5091547978 @default.
- W2601697433 hasConcept C126322002 @default.
- W2601697433 hasConcept C143998085 @default.
- W2601697433 hasConcept C159110408 @default.
- W2601697433 hasConcept C2779134260 @default.
- W2601697433 hasConcept C2779951463 @default.
- W2601697433 hasConcept C2780007613 @default.
- W2601697433 hasConcept C2780076729 @default.
- W2601697433 hasConcept C3019006561 @default.
- W2601697433 hasConcept C71924100 @default.
- W2601697433 hasConceptScore W2601697433C126322002 @default.
- W2601697433 hasConceptScore W2601697433C143998085 @default.
- W2601697433 hasConceptScore W2601697433C159110408 @default.
- W2601697433 hasConceptScore W2601697433C2779134260 @default.
- W2601697433 hasConceptScore W2601697433C2779951463 @default.
- W2601697433 hasConceptScore W2601697433C2780007613 @default.
- W2601697433 hasConceptScore W2601697433C2780076729 @default.
- W2601697433 hasConceptScore W2601697433C3019006561 @default.
- W2601697433 hasConceptScore W2601697433C71924100 @default.
- W2601697433 hasLocation W26016974331 @default.
- W2601697433 hasOpenAccess W2601697433 @default.
- W2601697433 hasPrimaryLocation W26016974331 @default.
- W2601697433 hasRelatedWork W1545484310 @default.
- W2601697433 hasRelatedWork W1599792451 @default.
- W2601697433 hasRelatedWork W2008799537 @default.
- W2601697433 hasRelatedWork W2039007892 @default.
- W2601697433 hasRelatedWork W2070929302 @default.
- W2601697433 hasRelatedWork W2105414227 @default.
- W2601697433 hasRelatedWork W2107398329 @default.
- W2601697433 hasRelatedWork W2115351357 @default.
- W2601697433 hasRelatedWork W2121743767 @default.
- W2601697433 hasRelatedWork W2127559749 @default.
- W2601697433 hasRelatedWork W2128785781 @default.
- W2601697433 hasRelatedWork W2142506642 @default.
- W2601697433 hasRelatedWork W2202408087 @default.
- W2601697433 hasRelatedWork W2331740984 @default.
- W2601697433 hasRelatedWork W2523062732 @default.
- W2601697433 hasRelatedWork W2890135700 @default.
- W2601697433 hasRelatedWork W2891902415 @default.
- W2601697433 hasRelatedWork W3116574834 @default.
- W2601697433 hasRelatedWork W3157098966 @default.
- W2601697433 hasRelatedWork W3169097194 @default.
- W2601697433 isParatext "false" @default.
- W2601697433 isRetracted "false" @default.
- W2601697433 magId "2601697433" @default.
- W2601697433 workType "article" @default.